Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -9.40
- Piotroski Score 5.00
- Grade Underperform
- Symbol (ACB)
- Company Aurora Cannabis Inc.
- Price $5.50
- Changes Percentage (0.18%)
- Change $0.01
- Day Low $5.45
- Day High $5.64
- Year High $9.35
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/07/2024
- Fiscal Year End N/A
- Average Stock Price Target $8.00
- High Stock Price Target $8.75
- Low Stock Price Target $1.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$57.91
- Trailing P/E Ratio -0.1
- Forward P/E Ratio -0.1
- P/E Growth -0.1
- Net Income $-69,326,000
Income Statement
Quarterly
Annual
Latest News of ACB
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
A MacBook Air for just under $250? Yes, please!
Own a grade-A refurbished Apple MacBook Air for just $249.97 (reg. $999). With a 13.3'' display, Intel Core i5 processor, 12-hour battery life, and 128GB SSD, this MacBook Air is perfect for work or s...
By New York Post | 2 weeks ago -
Pacific Biosciences of California, Inc. (PACB): Among the Worst ARK Stocks According to Short Sellers
The article discusses Cathie Wood's ARK Investment strategy, focusing on disruptive innovation stocks. It highlights the performance of some top stocks and mentions Pacific Biosciences of California, ...
By Yahoo! Finance | 3 weeks ago -
Apple Loop: Apple iPhone 16 Pro Details, MacBook Pro's Glass Design, iPhone SE Leaks
This week in Apple news: iPhone 16 Pro launch details, iPhone SE specs leak, iPad Mini hints, smaller Apple Watch 10, glass MacBook Pro, and changes to Apple's accessories. Stay tuned for the Glowtime...
By Forbes | 4 weeks ago
